Showing results (201-210 of 342) with videos related to
Sort By:
Pageof 35
Blood Cells, Molecules & Diseases|December 7, 2007
Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic interventionPeter J Meikle, Philip D Whitfield, Tina Rozaklis, et al.Journal of Clinical Medicine|September 9, 2022
Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)Derralynn A Hughes, Patrick Deegan, Pilar Giraldo, et al.International Journal of Molecular Sciences|February 15, 2022
Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?Tama Dinur, Peter Bauer, Christian Beetz, et al.American Journal of Hematology|September 29, 2018
Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trialElena Lukina, Nora Watman, Marta Dragosky, et al.Journal of Inherited Metabolic Disease|August 2, 2018
Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfaAri Zimran, Tama Dinur, Shoshana Revel-Vilk, et al.Journal of Clinical Medicine|June 28, 2023
Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on "Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158"Derralynn A Hughes, Patrick Deegan, Pilar Giraldo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemiaJohn Moore, Ian Nivison-Smith, Kim Goh, et al.Blood Cells, Molecules & Diseases|November 12, 2010
The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher RegistryBarry Rosenbloom, Manisha Balwani, Jeff M Bronstein, et al.Blood Cells, Molecules & Diseases|May 21, 2013
Miglustat therapy in type 1 Gaucher disease: clinical and safety outcomes in a multicenter retrospective cohort studyDavid J Kuter, Atul Mehta, Carla E M Hollak, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2011
The effect of folinic acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplantsNicholas M Murphy, Mary Diviney, Jeff Szer, et al.Pageof 35